No valuation for ONL Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($132.5M) and the funding record below are the closest available signals.
- ·The complete investor list: 26 names
- ·Watch ONL Therapeutics: the Monday email on marks, rounds and moves
ONL Therapeutics funding history
10 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2024 | Later Stage VC | $60.0M | ▮ | ▮ |
| Feb 2024 | Early Stage VC | $10.0M | ▮ | ▮ |
| Mar 2023 | Seed Round | $5.0M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $26.8M | ▮ | ▮ |
| Oct 2020 | Seed Round | $2.0M | ▮ | ▮ |
| Aug 2019 | Seed Round | $3.0M | ▮ | ▮ |
| + 4 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
How much has ONL Therapeutics raised?
ONL Therapeutics has raised $133 million across 10 recorded rounds since 2014. The largest was a $10 million early-stage round in Feb 2024; the most recent was a $60 million later-stage round in Sep 2024.
ONL Therapeutics has filed 10 Form Ds with the SEC since 2014, most recently in Sep 2024 ($60 million sold to 35 investors).
How ONL Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ONL Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about ONL Therapeutics
- How much has ONL Therapeutics raised?
- ONL Therapeutics has raised $132.5M in total funding across 10 recorded rounds.
- When did ONL Therapeutics last raise?
- ONL Therapeutics last raised in Sep 2024 (Later Stage VC), raising $60.0M.